Healthcare and pharmaceutical
Political intelligence for public affairs and government relations in the healthcare and pharmaceuticals sector
DeHavilland healthcare and pharma
The politics of health
Few subjects are as broad or as personal as health. From lessons of the Covid-19 pandemic to the global competition facing European pharma and MedTech, the sector is dealing with unprecedented challenges and opportunities. DeHavilland’s clients in the health industry can easily navigate this landscape with the support of our dedicated in-house experts.
DeHavilland political intelligence for healthcare and pharmaceutical
Monitor what matters
Health and pharmaceutical policy continue to expand, covering issues from preparedness and public health to the EU framework of pharmaceutical incentives and rewards (patents, exclusivity rights, SPCs), and medical devices. Developments in digitalisation and data also play a central role, with the European Health Data Space already reshaping the way health information is shared across borders.
DeHavilland’s in-house analysts provide both the big picture and specific detail, so you can receive real-time updates on the topics that impact your organisation. This includes legislation such as the Pharmaceutical Package, Critical Medicines Act and the Biotech Act, as well as major strategies like the Cardiovascular Health Plan and the Strategy for European Life Sciences.
Map your stakeholders
EU health policy is shaped by a wide range of actors from MEPs, Commission officials, national representatives, and EU agencies to industry stakeholders and civil society. Identifying and engaging the right contacts is vital for building influence.
DeHavilland People provides access to thousands of policymakers, regulators and sector leaders, with biographical details and contact information curated by experts. This intelligence enables organisations to establish productive, long-term relationships with the decision-makers shaping health and pharmaceutical policy.
Save time on policy
From the revision of the pharmaceutical legislation to medical countermeasures and stockpiling, including the European Health Data Space, EU health policy continues to evolve a lot and processing the latest information takes time and resources.
DeHavilland’s health consultants are embedded in the sector and can quickly contextualise reports and legislative updates, drawing out the key points that matter to you.
Plan ahead
Healthcare and pharmaceutical policy remains significant for the EU though its future prominence on the political agenda is shaped by shifting budgetary priorities and broader geopolitical pressures. Organisations need to anticipate developments before they materialise.
DeHavilland’s horizon scanning tools and daily updates keep you abreast of the future of health, so you can plan proactively and avoid unexpected risk.
Find out more about our Health and Pharma services
Register for a free 2-week trial
We use this data to ensure you get the information you want. Please read our Privacy Policy to find out more.